Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. MDS Diagnostic Spectrum

    ... stratification variables in these chronic myeloid neoplasms, prognostic scoring systems used for individual disorders are distinct. Use this ... IPSS Greenberg P, et al. Revised international prognostic scoring system for myelodysplastic syndromes ...

    Topic section last updated 03/11/2016 - 12:23am.

  2. Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy from the European Leukemianet Low Risk MDS (EUMDS) Registry

    ... Pierre Fenaux, MD, PhD16 Many doctors use the International Prognostic Scoring System (IPSS) to evaluate each patient’s ...

    Research Review last updated 05/02/2016 - 9:27am.

  3. What is My Doctor thinking?: MDS Classification, IPSS and IPSS-R Scoring Systems for MDS

    ... The International Prognostic Scoring System (IPSS) is a classification tool used by doctors to ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  4. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low

    ... anemia and thrombocytopenia due to International Prognostic Scoring System (IPSS) lower risk myelodysplastic syndromes (MDS). ...

    Clinical Trial last updated 04/27/2016 - 9:52am.

  5. Specialized technique effective in identifying chromosomal abnormalities, improving prognosis for MDS

    ... Abstract # 6521 To date, the most widely used prognostic classification system for myelodysplastic syndrome (MDS) is the International Prognostic Scoring System (IPSS). The first IPSS was derived ...

    Research Review last updated 05/02/2016 - 9:31am.

  6. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... syndrome either intermediate 1 or 2, or high risk by the International Prognostic Scoring System Chronic myelogenous leukemia (CML) in ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  7. A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02158936 ...

    Clinical Trial last updated 04/27/2016 - 1:28pm.

  8. Myelodysplastic Syndromes are a collection of diseases with common, but also different characteristics

    ... of the disease.  The latter is provided by the International Prognostic Scoring System (IPSS).  The newest version of IPSS classifies ...

    Research Review last updated 05/02/2016 - 9:22am.

  9. Sapacitibine shows promise for high-risk MDS patients

    ... be based on the patient’s age, performance status, and International Prognostic Scoring System (IPSS and IPSS-Revised) subgroup classification. ...

    Research Review last updated 05/02/2016 - 9:30am.

  10. A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 Mutation (AML)

    ... as ≥ 10% peripheral blood or marrow blasts and international Prognostic Scoring System [IPSS] score ≥ 2) and relapsed or refractory to ...

    Clinical Trial last updated 05/09/2016 - 4:09pm.